Vycor Medical (VYCO) Cash from Discontinued Operations (2019 - 2026)
Vycor Medical (VYCO) reported Cash from Discontinued Operations of 1117.0 for Q1 2026, up 2179.59% year-over-year from 49.0 in Q1 2025, and up 262.66% quarter-over-quarter from 308.0 in Q4 2025.
Vycor Medical (VYCO) Cash from Discontinued Operations (2019 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 8 years of Cash from Discontinued Operations data on file, last reported at 1117.0 in Q1 2026.
- Cash from Discontinued Operations for Q1 2026 came in at 1117.0, up 2179.59% year-over-year; the trailing twelve-month figure through Mar 2026 was 1704.0 (up 764.97% YoY), and the FY2025 annual result was 636.0, up 154.4% from the prior year.
- Cash from Discontinued Operations advanced to 1117.0 in Q1 2026 per VYCO's latest filing, from 308.0 in the prior quarter.
- Over five years, Cash from Discontinued Operations peaked at 1117.0 in Q1 2026 and troughed at 1116.0 in Q2 2022.
- A 5-year average of 65.65 and a median of 53.0 in 2024 frame the typical range for Cash from Discontinued Operations.
- The sharpest annual moves came in 2023 and 2026: Cash from Discontinued Operations plunged 287.82% in 2023, then jumped 2179.59% in 2026.
- A 5-year view of Cash from Discontinued Operations shows it stood at 322.0 in 2022, then jumped by 55.59% to 143.0 in 2023, then surged by 137.06% to 53.0 in 2024, then soared by 481.13% to 308.0 in 2025, then surged by 262.66% to 1117.0 in 2026.
- Business Quant data shows VYCO's Cash from Discontinued Operations at 1117.0 in Q1 2026, 308.0 in Q4 2025, and 53.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Vycor Medical | - | - | 375,153.00 | 1,117.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,117.00 |
| Mar 31, 2026 | 1,117.00 |
| Dec 31, 2025 | 308.00 |
| Dec 31, 2025 | 308.00 |
| Sep 30, 2025 | 53.00 |
| Sep 30, 2025 | 53.00 |
| Jun 30, 2025 | 226.00 |
| Jun 30, 2025 | 226.00 |
| Mar 31, 2025 | 49.00 |
| Mar 31, 2025 | 49.00 |
| Dec 31, 2024 | 53.00 |
| Dec 31, 2024 | 53.00 |
| Sep 30, 2024 | 47.00 |
| Sep 30, 2024 | 47.00 |
| Jun 30, 2024 | 48.00 |
| Jun 30, 2024 | 48.00 |
| Mar 31, 2024 | 102.00 |
| Mar 31, 2024 | 102.00 |
| Dec 31, 2023 | -143.00 |
| Dec 31, 2023 | -143.00 |